Clinical Trial Update: Efficacy and Safety of Longidaze in the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia [NA]

View source ↗

Summary

A completed clinical trial assessing the efficacy and safety of Longidaze for lower urinary tract symptoms associated with benign prostatic hyperplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Longidaze

Snippet

Sponsor: NPO Petrovax | Conditions: Lower Urinary Tract Symptoms, Prostatic Hyperplasia | NA | Status: COMPLETED